Kenyan drug agency develops draft guidelines for drug registration
This article was originally published in SRA
Kenya’s drug regulatory authority, the Pharmacy & Poisons Board, has issued draft guidelines on the registration of pharmaceutical products, including active pharmaceutical ingredients and finished pharmaceutical products1-3.
You may also be interested in...
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.